The adaptive clinical trial design offers researchers the bold capability to make alterations in trial protocols by analyzing ...

Challenges, Innovations, and Hope for the FutureClinical trials are the foundation of modern medicine, guiding the ...

A blend of FSO and FSP models in the landscape of artificial intelligence can ensure CROs stay up to date with the unique ...

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage pharmaceutical company focused on developing the next ...

Clinical trials, traditionally plagued by low success rates and high operational costs, are being reengineered through AI ...

Deepcoin, a leading global crypto trading platform, has unveiled a fully revamped website and app experience. Designed with a ...

In the CheckMate 274 study, adjuvant nivolumab demonstrated a significant improvement in disease-free survival (DFS) and showed a trend toward improved overall survival (OS) in an unselected ...

Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...

Research suggests that AI chatbots can reduce anxiety during wartime, but human therapy delivers better results.

Most cancer deaths happen because the cancer cells become resistant to drugs. Adaptive therapies could fix that. Antimicrobial resistance is a major health threat that kills more than a million people ...

The rise of GLP-1 agonist therapies has transformed obesity treatment, delivering unprecedented results and revealing their ...